Condition
Logopenic Variant Primary Progressive Aphasia
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07260253Not ApplicableRecruiting
Remotely-supervised Neuromodulation in PPA
NCT07219680Not ApplicableRecruiting
Intervention for Communication Quality of Life in Primary Progressive Aphasia
NCT04188067Not ApplicableCompletedPrimary
TMS for the Treatment of Primary Progressive Aphasia
NCT03406429Early Phase 1CompletedPrimary
rTMS as a Treatment for PPA
Showing all 4 trials